Drug Discovery News and Research

RSS
The drug discovery process begins with recognizing a disease or clinical condition in which there is a lack of adequate medical treatment. Once a potential drug has been identified, pre-clinical research can begin. This process includes several stages; the first of which involves identifying and validating the prospective drug’s target through assay development, high throughput screening, hit identification and finally, lead optimization. Once the pre-clinical process is complete, the newly synthesized drug candidate is selected for future clinical development.
A new book on ovarian cancer

A new book on ovarian cancer

ELRIG UK and British Pharmacological Society form strategic alliance to improve education, drive drug discovery

ELRIG UK and British Pharmacological Society form strategic alliance to improve education, drive drug discovery

Study shows nilotinib drug is safe and well tolerated in patients with Parkinson's disease

Study shows nilotinib drug is safe and well tolerated in patients with Parkinson's disease

Seafood consumption and mercury concentrations in vulnerable coastal Florida population

Seafood consumption and mercury concentrations in vulnerable coastal Florida population

Human genetics evidence predictive of drug development success, study shows

Human genetics evidence predictive of drug development success, study shows

New software to help researchers study specific information about proteins

New software to help researchers study specific information about proteins

Experimental Alzheimer’s drugs show promise

Experimental Alzheimer’s drugs show promise

Stilla Technologies announces key leadership hires

Stilla Technologies announces key leadership hires

SP Scientific launches the HT Series 3i Evaporators

SP Scientific launches the HT Series 3i Evaporators

Experts say cancer research is making more progress that people think

Experts say cancer research is making more progress that people think

Fluidic Analytics launches breakthrough protein analysis device at PEGS 2019

Fluidic Analytics launches breakthrough protein analysis device at PEGS 2019

Intellegens and Optibrium announce success in the Open Source Malaria global initiative

Intellegens and Optibrium announce success in the Open Source Malaria global initiative

Biosero and RORZE Lifescience collaborate to commercialize Green Button Go Automation Scheduling Software in Asia

Biosero and RORZE Lifescience collaborate to commercialize Green Button Go Automation Scheduling Software in Asia

Coriell scientist awarded grant to explore epigenetic drivers of breast cancer

Coriell scientist awarded grant to explore epigenetic drivers of breast cancer

Pharma’s take on the Pelosi drug-pricing bill: Fair warning or fearmongering?

Pharma’s take on the Pelosi drug-pricing bill: Fair warning or fearmongering?

Georgia State professor selected as National Academy of Inventors Fellow

Georgia State professor selected as National Academy of Inventors Fellow

ADDF announces new awards through its Diagnostics Accelerator initiative

ADDF announces new awards through its Diagnostics Accelerator initiative

Newly developed cell models can open up new avenues for ocular drug discovery

Newly developed cell models can open up new avenues for ocular drug discovery

LUNAC-led drug discovery project receives funding under Innovate UK’s Biomedical Catalyst program

LUNAC-led drug discovery project receives funding under Innovate UK’s Biomedical Catalyst program

Metrion and LifeArc extend neuroscience-focused ion channel drug discovery collaboration

Metrion and LifeArc extend neuroscience-focused ion channel drug discovery collaboration